MedTrace Logo

The Effect of Vitamin A on Atherosclerosis

NCT01414972 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2011-08-11

No results posted yet for this study

Summary

The aim of this study is the comparison between the effects of supplementation with 25000 IU preformed vitamin A (retinyl palmitate) or placebo for 4 months on gene expression of T CD4+ lymphocyte in atherosclerotic patients(documented with angiography).

Conditions

Interventions

DRUG

Vitamin A

1 cap vitamin A 25000 IU/day for 3 month

DRUG

placebo

1 cap placebo/day for 3 month

Sponsors & Collaborators

  • Tehran University of Medical Sciences

    lead OTHER

Principal Investigators

  • Ali Akbar saboor Yaraghi, PhD · Tehran University of Medical Sciences

  • Azadeh Mottaghi, PhD student · Tehran University of Medical Siences

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2011-01-31
Completion
2011-11-30

Countries

  • Iran

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01414972 on ClinicalTrials.gov